{"id":648842,"date":"2023-04-25T14:04:01","date_gmt":"2023-04-25T14:04:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=648842"},"modified":"2023-04-25T14:04:01","modified_gmt":"2023-04-25T14:04:01","slug":"chronic-venous-insufficiency-market-epidemiology-analysis-leading-companies-and-competitive-analysis-by-delveinsight-companies-verigraft-serenagroup","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/chronic-venous-insufficiency-market-epidemiology-analysis-leading-companies-and-competitive-analysis-by-delveinsight-companies-verigraft-serenagroup_648842.html","title":{"rendered":"Chronic Venous Insufficiency Market & Epidemiology Analysis, Leading Companies And Competitive Analysis By DelveInsight | Companies – Verigraft, SerenaGroup"},"content":{"rendered":"
\n
\"Chronic<\/a><\/div>\n
\n
Chronic Venous Insufficiency Market<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Chronic Venous Insufficiency- Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Chronic Venous Insufficiency, historical and forecasted epidemiology as well as the Chronic Venous Insufficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n

DelveInsight has launched a new report on “Chronic Venous Insufficiency – Market Insights, Epidemiology, and Market Forecast-2032”.<\/a><\/p>\n

DelveInsight’s “Chronic Venous Insufficiency – Market Insights, Epidemiology, and Market Forecast-2032″<\/a> report delivers an in-depth understanding of the Chronic Venous Insufficiency, historical and forecasted epidemiology as well as the Chronic Venous Insufficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

Some of the key facts of the Report:<\/strong><\/p>\n

    \n
  1. As per the study Chronic Venous Insufficiency (CVI) commonly affects lower limbs with a prevalence ranging between 25–40% and 10–20% in women and men, respectively. The annual incidence is 2–6% in women and 1.9% in men.<\/li>\n
  2. As per the study conducted the greater the age the higher the prevalence and the more advanced the CVD. Ninety-nine percent of the patients required some form of treatment, with a greater proportion among women. Sclerotherapy, endothermal ablation, or surgery was required by 4% of the patients.<\/li>\n<\/ol>\n

    Key benefits of the report:<\/strong><\/p>\n

      \n
    1. Chronic Venous Insufficiency  market report covers a descriptive overview and comprehensive insight of the Chronic Venous Insufficiency  epidemiology and Chronic Venous Insufficiency  market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)<\/li>\n
    2. The Chronic Venous Insufficiency market report provides insights on the current and emerging therapies.<\/li>\n
    3. Chronic Venous Insufficiency market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/li>\n
    4. The Chronic Venous Insufficiency market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Chronic Venous Insufficiency market.<\/li>\n<\/ol>\n

      Got queries? Click here to know more about Chronic Venous Insufficiency Market Landscape.<\/a><\/strong><\/p>\n

      Chronic Venous Insufficiency Overview<\/strong><\/p>\n

      Chronic venous insufficiency (CVI) typically refers to lower extremity edema, skin trophic changes, and discomfort secondary to venous hypertension. Chronic venous insufficiency pathophysiology is either due to reflux (backward flow) or obstruction of venous blood flow. Chronic venous insufficiency can develop from the protracted valvular incompetence of superficial veins, deep veins, or perforating veins that connect them. In all cases, the result is venous hypertension of the lower extremities.<\/p>\n

      The key players involved in the Chronic Venous Insufficiency market<\/a>:<\/strong><\/p>\n